<DOC>
	<DOCNO>NCT02081963</DOCNO>
	<brief_summary>This multi-centered , randomize , control study ass efficacy , indication adverse reaction combine administration nebulized amikacin patient acute exacerbation non-cystic fibrosis bronchiectasis evaluate whether inhaled antibiotic likely cause bacterial resistance .</brief_summary>
	<brief_title>Combined Administration Nebulized Amikacin Patients With Acute Exacerbation Non-Cystic Fibrosis Bronchiectasis</brief_title>
	<detailed_description>Objective : To assess efficacy , indication adverse reaction combine administration nebulized amikacin patient acute exacerbation non-cystic fibrosis bronchiectasis evaluate whether inhaled antibiotic likely cause bacterial resistance . Methods : Patients acute exacerbation non-cystic fibrosis bronchiectasis randomly assign observer group ( participant receive nebulized amikacin BID 14 day combination standard treatment ) control group ( participant receive nebulized 0.9 % saline BID 14 day combination standard treatment ) . The primary endpoint bacterial clearance rate sputum . Expected result : Compared control group , bacterial clearance rate sputum observer Group increase significantly .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>Male female study subject ≥18 year age ≤80 year age ; Confirmed diagnosis idiopathic bronchiectasis postinfectious bronchiectasis ; Confirmation infection Pseudomonas aeruginosa screening ; Are sensitive amikacin ; Acute exacerbation bronchiectasis . Bronchiectasis due special cause ; Smokers ; Are associate bronchial asthma ; Have serious active medical psychiatric illness ; Be allergic amikacin tolerant nebulised amikacin ( FEV1 reduce ≥15 % inhale amikacin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Nebulized amikacin ;</keyword>
	<keyword>Non-Cystic Fibrosis Bronchiectasis ;</keyword>
	<keyword>Bacterial clearance rate sputum；</keyword>
	<keyword>Acute exacerbation .</keyword>
</DOC>